Skip to main content


2016 publcations (for more publications, please go to pubmed)

1. Boakye CH, Patel K, Doddapaneni R, Bagde A, Behl G, Chowdhury N, Safe S, Singh M. Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention. Colloids and surfaces B, Biointerfaces. 2016;143:156-167.

2. Delgado E, Boisen MM, Laskey R, Chen R, Song C, Sallit J, Yochum ZA, Andersen CL, Sikora MJ, Wagner J, Safe S, Elishaev E, Lee A, Edwards RP, Haluska P, Tseng G, Schurdak M, Oesterreich S. High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome. Gynecologic oncology. 2016;141(2):348-356.

3. Goldberg AA, Draz H, Montes-Grajales D, Olivero-Verbel J, Safe SH, Sanderson JT. Erratum: 3,3'-Diindolylmethane (DIM) and its ring-substituted halogenated analogs (ring-DIMs) induce differential mechanisms of survival and death in androgen-dependent and-independent prostate cancer cells. Genes & cancer. 2016;7(1-2):59.

4. Hedrick E, Cheng Y, Jin UH, Kim K, Safe S. Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells. Oncotarget. 2016.

5. Hedrick E, Lee SO, Doddapaneni R, Singh M, Safe S. NR4A1 Antagonists Inhibit beta1-Integrin-Dependent Breast Cancer Cell Migration. Molecular and cellular biology. 2016;36(9):1383-1394.

6. Kasiappan R, Safe SH. ROS-Inducing Agents for Cancer Chemotherapy. 2016. 2016;1(1):16.

7. Safe S, Jin UH, Morpurgo B, Abudayyeh A, Singh M, Tjalkens RB. Nuclear receptor 4A (NR4A) family - orphans no more. The Journal of steroid biochemistry and molecular biology. 2016;157:48-60.

8. Takeuchi H, Taoka R, Mmeje CO, Jinesh GG, Safe S, Kamat AM. CDODA-Me decreases specificity protein transcription factors and induces apoptosis in bladder cancer cells through induction of reactive oxygen species. Urologic oncology. 2016.

9. Ying W, Tseng A, Chang RC, Wang H, Lin YL, Kanameni S, Brehm T, Morin A, Jones B, Splawn T, Criscitiello M, Golding MC, Bazer FW, Safe S, Zhou B. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Scientific reports. 2016;6:20176.


ROS-inducing Agents for Cancer Chemotherapy,